eXoZymes Inc. has filed a Current Report on Form 8-K with the U.S. Securities and Exchange Commission dated October 9, 2026. The filing was submitted to satisfy reporting obligations under the Securities Exchange Act of 1934.
The company, incorporated in Nevada and listed on the Nasdaq Capital Market under the symbol EXOZ, attached an Investor Presentation as part of Item 8.01 of the report. The presentation is dated October 6, 2026.
According to the filing, the attached document is intended for distribution to investment bankers, other participants in potential offerings, and current and potential investors in the company’s securities.
Item 9.01 of the report details the exhibits included in the filing. Exhibit 99.1 is identified as the Investor Presentation of eXoZymes Inc. dated October 6, 2026. The report also includes the standard cover page for the filing.
